Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07406087 · ClinicalTrials.gov registry record · NA

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

A NA study, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
25
Enrollment target

NCT07406087: Recruiting NA study, sponsored by Kaiser Permanente.

NCT07406087 is a NA study that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07406087, a NA study, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 milestones and receipt of the UH3 award. The primary objectives in the UG3 phase of the study are to adapt and tailor an existing PN program to meet the needs of AYA cancer survivors and the local clinical context via (a) interviews with key stakeholders (patients, clinicians, administrators) and (b) guidance from our AYA Primary Care Survivorship Council. The investigators will conduct a pilot study of the adapted PN program and refine the program to enhance acceptability to patients and clinicians, enhance feasibility and effectiveness, and develop and pilot evaluation tools and methods prior to the start of the UH3 phase of the trial, which will be a larger trial. Objectives will be updated for the UH3 phase once awarded.

Primary Outcome

Patient survey outcome; 8 items measured on a Likert scale (1-5) with higher scores associated with higher health competence

Interventions

  • BEHAVIORAL Adapted patient navigation program targeting adolescent and young adult cancer survivors

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2026-03-15
Est. Completion 2027-08
Phase NA
Kaiser Permanente

294 total trials

What NCT07406087 shows while recruiting

NCT07406087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Adapted patient navigation program targeting adolescent and young adult cancer survivors is the first listed.

NCT07406087 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07406087 about?

NCT07406087 is a clinical study titled "Navigation Intervention for Adolescent and Young Adult Cancer Survivors". The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPS...

What is the current status of trial NCT07406087?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-03-15. Estimated completion is 2027-08.

What interventions are being tested in trial NCT07406087?

The interventions under investigation include: Adapted patient navigation program targeting adolescent and young adult cancer survivors (BEHAVIORAL).

Who is sponsoring clinical trial NCT07406087?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07406087's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07406087, the US trial registry maintained by the National Library of Medicine. NCT07406087 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.